Dairy Based Probiotic Intervention and Cognitive, Emotional, and Inflammatory Outcomes

Sponsor
University of Idaho (Other)
Overall Status
Completed
CT.gov ID
NCT04643080
Collaborator
Kansas State University (Other)
47
4
2
4.3
11.8
2.8

Study Details

Study Description

Brief Summary

The purpose of this study was to determine the effect of dairy-based probiotics on cognitive function, emotional wellbeing, and inflammation. Subjects were assigned to either consume 6 oz of yogurt/day or abstain from consuming yogurt and other probiotic-containing foods for 12 weeks. Subjects completed baseline testing and 12-week follow-up testing consisting of a laboratory blood draw to assess inflammatory biomarkers, and a computerized assessment to evaluate cognitive and emotional wellbeing measures.

Condition or Disease Intervention/Treatment Phase
  • Other: Yogurt
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
47 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Supportive Care
Official Title:
Effects of a 12-week Dairy-based Probiotic Dietary Intervention on Cognitive Performance, Emotional Well-being, and Inflammation in Older Adults
Actual Study Start Date :
Mar 7, 2019
Actual Primary Completion Date :
Jul 15, 2019
Actual Study Completion Date :
Jul 15, 2019

Arms and Interventions

Arm Intervention/Treatment
No Intervention: Control

Subjects were asked to avoid consuming fermented foods for 12 weeks.

Experimental: Yogurt

Subjects were asked to consume 6 oz. of yogurt daily for 12 weeks.

Other: Yogurt
6 oz. of a commercially available yogurt were provided daily for 12 weeks

Outcome Measures

Primary Outcome Measures

  1. Change in Fluid Cognition Composite from Baseline to 12-weeks [Change from baseline fluid cognition composite score at 12-weeks]

    Subjects completed a battery of computerized cognitive assessments at baseline and 12-weeks, using the NIHToolbox for Assessment of Neurological and Behavioral Function application. The fluid cognition composite score was derived from scores on the Flanker Inhibitory Control and Attention Test, Dimensional Change Card Sort Test, Picture Sequence Memory Test, Pattern Comparison Processing Speed Test, and List Sorting Working Memory test.

  2. Change in Executive Function from Baseline to 12-weeks [Change from baseline executive function test scores at 12 weeks]

    Subjects completed a battery of computerized cognitive assessments at baseline and 12-weeks, using the NIHToolbox for Assessment of Neurological and Behavioral Function application. Executive function was assessed by the Flanker Inhibitory Control and Attention Test and the Dimensional Change Card Sort Test.

  3. Change in Attention from Baseline to 12-weeks [Change from baseline attention test scores at 12 weeks]

    Subjects completed a battery of computerized cognitive assessments at baseline and 12-weeks, using the NIHToolbox for Assessment of Neurological and Behavioral Function application. Attention was assessed by the Flanker Inhibitory Control and Attention Test.

  4. Change in Working Memory from Baseline to 12-weeks [Change from baseline working memory test scores at 12 weeks]

    Subjects completed a battery of computerized cognitive assessments at baseline and 12-weeks, using the NIHToolbox for Assessment of Neurological and Behavioral Function application. Working Memory was assessed by the List Sorting Working Memory test.

  5. Change in Processing Speed from Baseline to 12-weeks [Change from baseline processing speed test scores at 12 weeks]

    Subjects completed a battery of computerized cognitive assessments at baseline and 12-weeks, using the NIHToolbox for Assessment of Neurological and Behavioral Function application. Processing Speed was assessed by the Pattern Comparison Processing Speed test.

  6. Change in Episodic Memory from Baseline to 12-weeks [Change in baseline episodic memory score at 12 weeks]

    Subjects completed a battery of computerized cognitive assessments at baseline and 12-weeks, using the NIHToolbox for Assessment of Neurological and Behavioral Function application. Episodic Memory was assessed by the Picture Sequence Memory test.

Secondary Outcome Measures

  1. Change in Negative Affect from Baseline to 12-weeks [Change from baseline negative affect test scores at 12 weeks]

    Subjects completed a battery of computerized self-reported questionnaires using the NIHToolbox for Assessment of Neurological and Behavioral Function. A Negative Affect summary score was derived from 5 individual assessments of anger affect, anger hostility, sadness, fear affect, and perceived stress.

  2. Change in Psychological Wellbeing [Change from baseline psychological satisfaction test scores at 12 weeks]

    Subjects completed a battery of computerized self-reported questionnaires using the NIHToolbox for Assessment of Neurological and Behavioral Function. A Psychological Wellbeing summary score was derived from 3 individual assessments of life satisfaction, meaning, and positive affect.

  3. Change in Social Satisfaction from Baseline to 12-weeks [Change from baseline social satisfaction test scores at 12 weeks]

    Subjects completed a battery of computerized self-reported questionnaires using the NIHToolbox for Assessment of Neurological and Behavioral Function. A Social Satisfaction summary score was derived from 5 individual assessments of friendship, loneliness, emotional support, instrumental support, and perceived rejection.

  4. Change in serum interleukin-6 concentration from baseline to 12 weeks [Change from baseline serum interleukin-6 concentration at 12 weeks]

    Serum samples were analyzed to determine concentrations of interleukin-6 (pg/mL).

  5. Change in serum tumor necrosis factor-alpha concentration from baseline to 12 weeks [Change from baseline serum tumor necrosis factor-alpha concentration at 12 weeks]

    Serum samples were analyzed to determine concentrations of tumor necrosis factor-alpha (pg/mL).

  6. Change in serum c-reactive protein concentration from baseline to 12 weeks [Change from baseline serum c-reactive protein concentration at 12 weeks]

    Serum samples were analyzed to determine concentrations of c-reactive protein (mg/L).

Eligibility Criteria

Criteria

Ages Eligible for Study:
50 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • ability to participate in a 12-week study

  • at least 50 years of age

  • not currently taking a probiotic dietary supplement

  • willing to refrain from consuming probiotic dietary supplements or fermented foods for 12-weeks

  • willing to have blood drawn twice

  • willing to consume yogurt daily for 12 weeks

Exclusion Criteria:

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of Idaho Boise Idaho United States 83702
2 University of Idaho Coeur d'Alene Idaho United States 83814
3 University of Idaho Pocatello Idaho United States 83201
4 Kansas State University Manhattan Kansas United States 66506

Sponsors and Collaborators

  • University of Idaho
  • Kansas State University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Annie Roe, Principal Investigator, University of Idaho
ClinicalTrials.gov Identifier:
NCT04643080
Other Study ID Numbers:
  • 18-203
First Posted:
Nov 24, 2020
Last Update Posted:
Nov 24, 2020
Last Verified:
Nov 1, 2020
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Annie Roe, Principal Investigator, University of Idaho
Additional relevant MeSH terms:

Study Results

No Results Posted as of Nov 24, 2020